Key Account Manager Bremen at Cytokinetics

Bremen, Bremen, Germany

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, CardiovascularIndustries

Requirements

Bachelor's Degree
5+ years of experience in biotech/pharma sales
Expertise in evaluation of territory market trends and strategic planning that drives results and exceeds sales objectives
Experience selling to complex accounts, identifying influential stakeholders, and meeting patient needs
Clinical acumen with a passion for understanding and championing the needs of customers and their patients
Agree to credentialing requirements for access to academic institutions, medical facilities, and organizations in the assigned territory
Willing and able to travel overnight, 25% to 75% depending on business needs and geography
Ability to demonstrate an acceptable driving record and valid driver’s license to operate a company vehicle
Experience as a rep with sole ownership of the territory (highly preferred)
Cardiology, rare disease, or specialty product experience (preferred)
Specialty product launch experience (preferred)
Experience with patient service hubs and specialty pharmacy distribution (preferred)
Knowledge of KOLs and key accounts within assigned territory (preferred)

Responsibilities

Deliver sales results, work autonomously, and serve as single point of accountability for the successful launch within your territory
Develop territory-specific account plans that identify, assess, and prioritize opportunities to meet customer needs by coordinating the efforts of a local integrated field team consisting of medical, payer, and patient navigation/support colleagues
Be a subject matter expert and resource to customers through the delivery of clinically relevant disease and product information while focusing on creating demand for the product launch
Communicate approved resources to HCPs for the benefit of HCM patients such as marketing materials, payer information, formulary coverage, patient support services, and educational programs

Skills

Key technologies and capabilities for this role

Key Account ManagementPharmaceutical SalesSales DeliveryRelationship BuildingClinical AcumenMarket AccessCross-functional CollaborationCardiology KnowledgeHypertrophic Cardiomyopathy

Questions & Answers

Common questions about this position

What experience is required for the Key Account Manager role?

A Bachelor's Degree is required along with 5+ years of experience in biotech/pharma sales. Experience as a rep with sole ownership of the territory is highly preferred, as is cardiology, rare disease, or specialty product experience, and specialty product launch experience.

What are Cytokinetics' core values?

The core values are: Patients are our North Star, Science is in our Soul, We > Me, and Make it Happen.

Is this a remote position or does it require being in Bremen?

This information is not specified in the job description.

What is the salary or compensation for this role?

This information is not specified in the job description.

What makes a strong candidate for this Key Account Manager position?

Strong candidates will have 5+ years in biotech/pharma sales with sole territory ownership experience, plus preferred expertise in cardiology, rare diseases, specialty products, and product launches, demonstrating strategic account management, clinical acumen, and entrepreneurial drive.

Cytokinetics

Develops drugs for muscle function disorders

About Cytokinetics

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

South San Francisco, CaliforniaHeadquarters

1998Year Founded

$58.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Risks

Increased competition could impact market share and profitability.

Potential delays in clinical trials could hinder drug commercialization.

Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

Differentiation

Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.

The company has a robust pipeline including omecamtiv mecarbil and aficamten.

Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Upsides

Recent investments indicate strong interest in muscle activators and inhibitors.

Strategic partnerships, like with Sanofi, expand market reach and potential revenue.

Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

Land your dream remote job 3x faster with AI

Try Jobo Free